Scientists have developed a new drug, KG5 that alters the structure of a cancer growth protein (enzyme called RAF), thus neutralizing it without any side-effect. This drug is expected to hit the market in 5years.
With this new medicine researchers from the School of Medicine at the University of California, hope to avoid the common problem of cancers developing resistance to treatment. They expect that the compound or its derivatives will be effective against a wide range of the fastest growing and most dangerous cancers.
New variants of KG5 are 100 times more
powerful than the original. Scientists hope that one of these more
potent compounds will soon enter clinical trials. The research has been published online in the journal Nature Medicine.